Experiencing some form of loss in later life is common, and many of us are not well prepared, says Daniel Heiser, PsyD, Senior Vice President, Behavio...
CMS has updated its methodology for the Long-Stay Antipsychotic Quality Measure, effective Jan. 1, 2026
Achieving clinical, regulatory, and operational success in long-term care hinges on having the right structures and processes in place.
In nursing homes, Quality Management (QM) practices are designed to promote an analytical, evidence-based model of resident care. QM empowers care tea...
Falls are common among nursing home residents, and medication review is one strategy that can help reduce the risk. About half of nursing home residen...
In dementia care, the right medications can make a difference in managing challenging behaviors. Historically, many physicians have prescribed antipsy...
Revised CMS guidance on informed consent for psychotropic medications emphasizes the resident's right to be fully informed and the right to accept or...
To meet CMS F605 guidelines, prescribing a psychotropic drug requires an “adequate indication for use”. Current practices in neuropharmacology provide...
Under recently revised CMS guidance for nursing homes, F605 imposes new requirements for nursing home staff who are managing aggressive behaviors in r...
For nursing home residents living with dementia, wandering behavior is common. Up to 70% will have at least one episode.
New CMS guidance for surveyors in long-term care aims to prevent the unnecessary use of psychotropic medications. It calls for scrutiny of any situati...
As revised CMS guidance takes hold in skilled nursing facilities, a heightened focus on diagnosis underlying the use of psychotropic medications is es...
